FDA/HHS/NOMINATIONS/TRUMP AS PRESIDENT/TRUMP PEOPLE: “President Trump said Friday [11-1-19] that he intended to nominate Dr. Stephen M. Hahn, a top executive at The University of Texas M.D. Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration. If he is confirmed by the Senate, Dr. Hahn would fill the vacancy left by Dr. Scott Gottlieb, who stepped down as commissioner in April. In doing so, he passed over the acting commissioner, Dr. Norman E. Sharpless, who had the support of previous commissioners and an array of patient groups. The Department of Health and Human Services said Friday that Dr. Sharpless would be returning to his role as director of the National Cancer Institute, which he previously held before taking over as acting commissioner. Dr. Brett Giroir, the assistant secretary for health, will fulfill the duties of acting commissioner while Dr. Hahn goes through the confirmation process.”
–Katie Thomas, “Trump to Nominate Stephen Hahn, Cancer Researcher, to Head F.D.A.,” The New York Times online, November 1, 2019